On June 21, 2024, the American Journal of Managed Care ran an article titled “Protecting the 340B Program Vital for Providing the Best Care to Patients With HIV” that detailed the essential role 340B plays in providing the best care possible to people living with HIV. RWC-340B Officers Emily Blaiklock and Bill Keeton were featured in the story and quoted extensively.

Read the full article here: https://www.ajmc.com/view/protecting-the-340b-program-vital-for-providing-the-best-care-to-patients-with-hiv

“340B doesn’t actually use or invest federal tax dollar money.” – Bill Keeton, chief advocacy officer, Vivent Health and RWC-340B Officer

“340B is really designed to help clinics…ensure that we are able to deliver comprehensive care to some of the nation’s most vulnerable individuals. – Bill Keeton

“[The Ryan White patient data report from 2021] states the US saw 18.4% increase in medical care costs due to inflation from the year 2015 to 2021. However, Ryan White funding remained stagnant…Ryan White clinics were able to utilize 340B program savings to offset these raising costs. It actually provided care to an additional 43,000 individuals living with HIV.” – Emily Blaiklock, vice president of Pharmacy, Positive Impact Health Centers and RWC-340B Officer

“So at the end of the day, the 340B program is designed to make sure that there is sustainability and financial stability within the safety net.” – Bill Keeton

“When somebody walks into a pharmacy like mine and can’t afford their medication, they walk out of our clinics with every medication that they need to manage their health. – Bill Keeton

“We strongly oppose any attempt to restrict the reach of the 340B program.” – Emily Blaiklock

“Any restrictions erode impact, they endanger health outcomes, and taxpayers will pay all pharmacy [while] pharma will profit.” – Emily Blaiklock